Quentin Van Meter
Paediatric endocrinologist and gender medicine critic
Few voices in the gender medicine debate carry the institutional weight of Quentin Van Meter. A paediatric endocrinologist who trained alongside John Money at Johns Hopkins, he spent four decades watching a clinical field he helped shape drift, in his view, away from evidence — testimony that lands with particular force as European health authorities reconsider their own protocols.
Quentin Van Meter's career offers a rare vantage point on the origins of modern gender medicine. Trained as a paediatric endocrinologist at Johns Hopkins University — where he worked alongside John Money, the psychologist whose theories on gender identity underpinned decades of clinical practice — he was present at the founding of the frameworks that WPATH would later codify into international standards of care. That proximity to the beginning is precisely what makes his account so striking.
In the Beyond Gender episode From John Money to Modern Gender Clinics: An Insider Speaks (no. 28, August 2025), Van Meter spoke with hosts Stella O'Malley, Mia Hughes and Dr Bret Alderman about his deepening disillusionment with WPATH, which he now regards as a scientifically unfounded advocacy body rather than a rigorous medical standards organisation. He outlined the risks he associates with puberty blockers, traced the ideological drift he observed over decades, and described his departure from the American Academy of Pediatrics — a break that led him to the American College of Pediatricians, of which he has served as president.
For European listeners the conversation is immediately relevant. Sweden, Finland and Denmark have already moved to restrict routine puberty-blocker prescribing for gender-dysphoric minors; England's Cass Review prompted a similar shift across the NHS; France, the Netherlands and Germany are conducting their own re-evaluations. Van Meter's insider account of how Money's contested findings were absorbed into mainstream clinical guidance — and how WPATH's successive standards of care cascaded into European protocols — provides historical grounding for policy discussions now under way in Brussels, Stockholm, Paris and Berlin.
Whether or not one shares his conclusions, hearing from a clinician who was in the room at the formative moments of modern gender medicine gives European audiences a perspective that domestic debate rarely supplies.
